ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiation Injury Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-33T6954
Home | Market Reports | Health| Pharmacy
Global Radiation Injury Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Radiation Injury Drugs Market Research Report 2025

Code: QYRE-Auto-33T6954
Report
September 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
FirstString Research Inc
PharmaIN Corp
Synedgen Inc
Tonix Pharmaceuticals Holding Corp.
Windtree Therapeutics Inc

Radiation Injury Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Radiation Injury Drugs Market

Radiation Injury Drugs Market

The global market for Radiation Injury Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Radiation Injury Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiation Injury Drugs.
The Radiation Injury Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiation Injury Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiation Injury Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Radiation Injury Drugs Market Report

Report Metric Details
Report Name Radiation Injury Drugs Market
CAGR 5%
Segment by Type
  • Aerosurf
  • BMX-001
  • C-2E2
  • C-2E5
  • Des-Asp Angiotensin 1
  • DG-3
  • Others
Segment by Application
  • ASCs
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company FirstString Research Inc, PharmaIN Corp, Synedgen Inc, Tonix Pharmaceuticals Holding Corp, Windtree Therapeutics Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Radiation Injury Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Radiation Injury Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Radiation Injury Drugs Market report?

Ans: The main players in the Radiation Injury Drugs Market are FirstString Research Inc, PharmaIN Corp, Synedgen Inc, Tonix Pharmaceuticals Holding Corp, Windtree Therapeutics Inc

What are the Application segmentation covered in the Radiation Injury Drugs Market report?

Ans: The Applications covered in the Radiation Injury Drugs Market report are ASCs, Hospital, Clinic, Others

What are the Type segmentation covered in the Radiation Injury Drugs Market report?

Ans: The Types covered in the Radiation Injury Drugs Market report are Aerosurf, BMX-001, C-2E2, C-2E5, Des-Asp Angiotensin 1, DG-3, Others

1 Radiation Injury Drugs Market Overview
1.1 Product Definition
1.2 Radiation Injury Drugs by Type
1.2.1 Global Radiation Injury Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Aerosurf
1.2.3 BMX-001
1.2.4 C-2E2
1.2.5 C-2E5
1.2.6 Des-Asp Angiotensin 1
1.2.7 DG-3
1.2.8 Others
1.3 Radiation Injury Drugs by Application
1.3.1 Global Radiation Injury Drugs Market Value by Application (2024 VS 2031)
1.3.2 ASCs
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Global Radiation Injury Drugs Market Size Estimates and Forecasts
1.4.1 Global Radiation Injury Drugs Revenue 2020-2031
1.4.2 Global Radiation Injury Drugs Sales 2020-2031
1.4.3 Global Radiation Injury Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Radiation Injury Drugs Market Competition by Manufacturers
2.1 Global Radiation Injury Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Radiation Injury Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Radiation Injury Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Radiation Injury Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Radiation Injury Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radiation Injury Drugs, Product Type & Application
2.7 Global Key Manufacturers of Radiation Injury Drugs, Date of Enter into This Industry
2.8 Global Radiation Injury Drugs Market Competitive Situation and Trends
2.8.1 Global Radiation Injury Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Radiation Injury Drugs Players Market Share by Revenue
2.8.3 Global Radiation Injury Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Radiation Injury Drugs Market Scenario by Region
3.1 Global Radiation Injury Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Radiation Injury Drugs Sales by Region: 2020-2031
3.2.1 Global Radiation Injury Drugs Sales by Region: 2020-2025
3.2.2 Global Radiation Injury Drugs Sales by Region: 2026-2031
3.3 Global Radiation Injury Drugs Revenue by Region: 2020-2031
3.3.1 Global Radiation Injury Drugs Revenue by Region: 2020-2025
3.3.2 Global Radiation Injury Drugs Revenue by Region: 2026-2031
3.4 North America Radiation Injury Drugs Market Facts & Figures by Country
3.4.1 North America Radiation Injury Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Radiation Injury Drugs Sales by Country (2020-2031)
3.4.3 North America Radiation Injury Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Radiation Injury Drugs Market Facts & Figures by Country
3.5.1 Europe Radiation Injury Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Radiation Injury Drugs Sales by Country (2020-2031)
3.5.3 Europe Radiation Injury Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiation Injury Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Radiation Injury Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Radiation Injury Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Radiation Injury Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Radiation Injury Drugs Market Facts & Figures by Country
3.7.1 Latin America Radiation Injury Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Radiation Injury Drugs Sales by Country (2020-2031)
3.7.3 Latin America Radiation Injury Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiation Injury Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiation Injury Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Radiation Injury Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Radiation Injury Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Radiation Injury Drugs Sales by Type (2020-2031)
4.1.1 Global Radiation Injury Drugs Sales by Type (2020-2025)
4.1.2 Global Radiation Injury Drugs Sales by Type (2026-2031)
4.1.3 Global Radiation Injury Drugs Sales Market Share by Type (2020-2031)
4.2 Global Radiation Injury Drugs Revenue by Type (2020-2031)
4.2.1 Global Radiation Injury Drugs Revenue by Type (2020-2025)
4.2.2 Global Radiation Injury Drugs Revenue by Type (2026-2031)
4.2.3 Global Radiation Injury Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Radiation Injury Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Radiation Injury Drugs Sales by Application (2020-2031)
5.1.1 Global Radiation Injury Drugs Sales by Application (2020-2025)
5.1.2 Global Radiation Injury Drugs Sales by Application (2026-2031)
5.1.3 Global Radiation Injury Drugs Sales Market Share by Application (2020-2031)
5.2 Global Radiation Injury Drugs Revenue by Application (2020-2031)
5.2.1 Global Radiation Injury Drugs Revenue by Application (2020-2025)
5.2.2 Global Radiation Injury Drugs Revenue by Application (2026-2031)
5.2.3 Global Radiation Injury Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Radiation Injury Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 FirstString Research Inc
6.1.1 FirstString Research Inc Company Information
6.1.2 FirstString Research Inc Description and Business Overview
6.1.3 FirstString Research Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 FirstString Research Inc Radiation Injury Drugs Product Portfolio
6.1.5 FirstString Research Inc Recent Developments/Updates
6.2 PharmaIN Corp
6.2.1 PharmaIN Corp Company Information
6.2.2 PharmaIN Corp Description and Business Overview
6.2.3 PharmaIN Corp Radiation Injury Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 PharmaIN Corp Radiation Injury Drugs Product Portfolio
6.2.5 PharmaIN Corp Recent Developments/Updates
6.3 Synedgen Inc
6.3.1 Synedgen Inc Company Information
6.3.2 Synedgen Inc Description and Business Overview
6.3.3 Synedgen Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Synedgen Inc Radiation Injury Drugs Product Portfolio
6.3.5 Synedgen Inc Recent Developments/Updates
6.4 Tonix Pharmaceuticals Holding Corp
6.4.1 Tonix Pharmaceuticals Holding Corp Company Information
6.4.2 Tonix Pharmaceuticals Holding Corp Description and Business Overview
6.4.3 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product Portfolio
6.4.5 Tonix Pharmaceuticals Holding Corp Recent Developments/Updates
6.5 Windtree Therapeutics Inc
6.5.1 Windtree Therapeutics Inc Company Information
6.5.2 Windtree Therapeutics Inc Description and Business Overview
6.5.3 Windtree Therapeutics Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Windtree Therapeutics Inc Radiation Injury Drugs Product Portfolio
6.5.5 Windtree Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiation Injury Drugs Industry Chain Analysis
7.2 Radiation Injury Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiation Injury Drugs Production Mode & Process Analysis
7.4 Radiation Injury Drugs Sales and Marketing
7.4.1 Radiation Injury Drugs Sales Channels
7.4.2 Radiation Injury Drugs Distributors
7.5 Radiation Injury Drugs Customer Analysis
8 Radiation Injury Drugs Market Dynamics
8.1 Radiation Injury Drugs Industry Trends
8.2 Radiation Injury Drugs Market Drivers
8.3 Radiation Injury Drugs Market Challenges
8.4 Radiation Injury Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
FirstString Research Inc
PharmaIN Corp
Synedgen Inc
Tonix Pharmaceuticals Holding Corp.
Windtree Therapeutics Inc
List of Tables
 Table 1. Global Radiation Injury Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Radiation Injury Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Radiation Injury Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Radiation Injury Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Radiation Injury Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Radiation Injury Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Radiation Injury Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Radiation Injury Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Radiation Injury Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Radiation Injury Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Radiation Injury Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Radiation Injury Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Radiation Injury Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Injury Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Radiation Injury Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Radiation Injury Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Radiation Injury Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Radiation Injury Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Radiation Injury Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Radiation Injury Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Radiation Injury Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Radiation Injury Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Radiation Injury Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Radiation Injury Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Radiation Injury Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Radiation Injury Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Radiation Injury Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Radiation Injury Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Radiation Injury Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Radiation Injury Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Radiation Injury Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Radiation Injury Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Radiation Injury Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Radiation Injury Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Radiation Injury Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Radiation Injury Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Radiation Injury Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Radiation Injury Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Radiation Injury Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Radiation Injury Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Radiation Injury Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Radiation Injury Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Radiation Injury Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Radiation Injury Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Radiation Injury Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Radiation Injury Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Radiation Injury Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Radiation Injury Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Radiation Injury Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Radiation Injury Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Radiation Injury Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Radiation Injury Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Radiation Injury Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Radiation Injury Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Radiation Injury Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Radiation Injury Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Radiation Injury Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Radiation Injury Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Radiation Injury Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Radiation Injury Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Radiation Injury Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Radiation Injury Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Radiation Injury Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Radiation Injury Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Radiation Injury Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Radiation Injury Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Radiation Injury Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Radiation Injury Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. FirstString Research Inc Company Information
 Table 71. FirstString Research Inc Description and Business Overview
 Table 72. FirstString Research Inc Radiation Injury Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. FirstString Research Inc Radiation Injury Drugs Product
 Table 74. FirstString Research Inc Recent Developments/Updates
 Table 75. PharmaIN Corp Company Information
 Table 76. PharmaIN Corp Description and Business Overview
 Table 77. PharmaIN Corp Radiation Injury Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. PharmaIN Corp Radiation Injury Drugs Product
 Table 79. PharmaIN Corp Recent Developments/Updates
 Table 80. Synedgen Inc Company Information
 Table 81. Synedgen Inc Description and Business Overview
 Table 82. Synedgen Inc Radiation Injury Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Synedgen Inc Radiation Injury Drugs Product
 Table 84. Synedgen Inc Recent Developments/Updates
 Table 85. Tonix Pharmaceuticals Holding Corp Company Information
 Table 86. Tonix Pharmaceuticals Holding Corp Description and Business Overview
 Table 87. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product
 Table 89. Tonix Pharmaceuticals Holding Corp Recent Developments/Updates
 Table 90. Windtree Therapeutics Inc Company Information
 Table 91. Windtree Therapeutics Inc Description and Business Overview
 Table 92. Windtree Therapeutics Inc Radiation Injury Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Windtree Therapeutics Inc Radiation Injury Drugs Product
 Table 94. Windtree Therapeutics Inc Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Radiation Injury Drugs Distributors List
 Table 98. Radiation Injury Drugs Customers List
 Table 99. Radiation Injury Drugs Market Trends
 Table 100. Radiation Injury Drugs Market Drivers
 Table 101. Radiation Injury Drugs Market Challenges
 Table 102. Radiation Injury Drugs Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Radiation Injury Drugs
 Figure 2. Global Radiation Injury Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Radiation Injury Drugs Market Share by Type: 2024 & 2031
 Figure 4. Aerosurf Product Picture
 Figure 5. BMX-001 Product Picture
 Figure 6. C-2E2 Product Picture
 Figure 7. C-2E5 Product Picture
 Figure 8. Des-Asp Angiotensin 1 Product Picture
 Figure 9. DG-3 Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Radiation Injury Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Radiation Injury Drugs Market Share by Application: 2024 & 2031
 Figure 13. ASCs
 Figure 14. Hospital
 Figure 15. Clinic
 Figure 16. Others
 Figure 17. Global Radiation Injury Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Radiation Injury Drugs Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Radiation Injury Drugs Sales (2020-2031) & (K Pcs)
 Figure 20. Global Radiation Injury Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Radiation Injury Drugs Report Years Considered
 Figure 22. Radiation Injury Drugs Sales Share by Manufacturers in 2024
 Figure 23. Global Radiation Injury Drugs Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Radiation Injury Drugs Players: Market Share by Revenue in Radiation Injury Drugs in 2024
 Figure 25. Radiation Injury Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Radiation Injury Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Radiation Injury Drugs Sales Market Share by Country (2020-2031)
 Figure 28. North America Radiation Injury Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Radiation Injury Drugs Sales Market Share by Country (2020-2031)
 Figure 32. Europe Radiation Injury Drugs Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Radiation Injury Drugs Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Radiation Injury Drugs Revenue Market Share by Region (2020-2031)
 Figure 40. China Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Radiation Injury Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Radiation Injury Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Radiation Injury Drugs Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Radiation Injury Drugs Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Radiation Injury Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Radiation Injury Drugs by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Radiation Injury Drugs by Type (2020-2031)
 Figure 62. Global Radiation Injury Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Radiation Injury Drugs by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Radiation Injury Drugs by Application (2020-2031)
 Figure 65. Global Radiation Injury Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 66. Radiation Injury Drugs Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions